I.C.G.E.B. International Centre for Genetic Engineering and Biotechnology
发明人:
申请号：
EP17160768.2
公开号：
EP3375458A1
申请日:
2017.03.14
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention refers to human microRNA hsa-miR-665 for the treatment or prevention of heart diseases associated with cardiac hypertrophy and consequent pathological remodeling of the heart, in particular for preventing and/or treating heart failure (HF). Vectors and pharmaceutical compositions comprising said miRNA for the disclosed uses are also within the scope of the present invention.
